Armon Interviewed About Compliance Issues
Bruce D. Armon, a Partner and Chair of the Life Sciences Practice Group, was interviewed by Jane Chin, Ph.D. and President, Medical Science Liaison (MSL) Institute, about compliance issues in 2007 that affect MSL's and pharmaceutical companies.
Mr. Armon discusses the difference between scientific exchange and promotion, and distinguishes between solicited and unsolicited requests. He also explains MSLs in peri-label ("early commercialization") activities.
The interview was also mentioned in the July 15, 2007 MSL Newsletter.